Organogenesis Holdings Inc - Ordinary Shares - Class A
ORGO
Get informed when a big investor buys or sells
+ FollowMarket Cap$231.61M
Close$
$0.30
83.5% downside
Current Fair Value
83.5% downsideOvervalued by 83.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $231.61 Million |
|---|---|
| Enterprise Value | $252.47 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.16 |
| Beta | 1.33 |
| Outstanding Shares | 128,674,548 |
Return
| Return on Equity | -52.20% |
|---|---|
| Return on Assets | -19.04% |
| Return on Invested Capital | -10.39% |
Valuation & Multiples
| P/E Ratio | -2.2 |
|---|---|
| PEG | -0.23 |
| Price to Sales | 0.6 |
| Price to Book Ratio | 0.9 |
| Enterprise Value to Revenue | 0.55 |
| Enterprise Value to EBIT | -6.95 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 0.45 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
$54.27 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
$52.10 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 88.43% |
|---|---|
| Total Calls | 36,900▲ 204.96% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 48.99%▼ 5.77% |
|---|---|
| Total Invested | $147.61M▼ 58.97% |
| Investors Holding | 121▼ 27.00% |
ESG Score
No data